Pacific Biosciences of California (PACB)

Pacific Biosciences of California stock price live, this page displays NASDAQ PACB stock exchange data. View the PACB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pacific Biosciences of California real time stock price chart below.

What Is the Pacific Biosciences of California Stock Price Today?
The Pacific Biosciences of California stock price today is 2.030.

What Is the Stock Symbol for Pacific Biosciences of California?
The stock symbol for Pacific Biosciences of California is "PACB."

What Stock Exchange Does Pacific Biosciences of California Trade On?
Pacific Biosciences of California is listed and trades on the NASDAQ stock exchange.

Is Pacific Biosciences of California a Good Stock to Buy?
Determining whether Pacific Biosciences of California—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.

You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PACB quote. (ISIN: US69404D1081)

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.